3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Neurofibroma, Plexiform
2
Squamous Cell Carcinoma of Head and Neck
1
Neurofibromatosis 1
1
Neurofibromatoses
1
Nerve Sheath Neoplasms
1
Myofibroma
1
Lymphedema
1
Lung Neoplasms
1
Leiomyoma
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Acute Lung Injury
1
Interventions
pycnogenols
2
Pentoxifylline
2
pirfenidone
1
pazopanib
1
Vitamin E
1
Tocopherols
1
Technetium Tc 99m Sulfur Colloid
1
Surgical Procedures, Operative
1
Standard of Care
1
Sodium Selenite
1
Sodium Chloride
1
Sentinel Lymph Node Biopsy
1
Radiotherapy
1
Pravastatin
1
Physical Therapy Modalities
1
Pharmaceutical Preparations
1
Methylene Blue
1
Mastectomy, Segmental
1
Mastectomy
1
Manual Lymphatic Drainage
1
Lymph Node Excision
1
Lipectomy
1
Ketoprofen
1
Indocyanine Green
1
Hyperbaric Oxygenation
1
Drug Therapy
1
Compression Bandages
1
Acupuncture Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Lymphedema
×
pirfenidone
×
Clear all
NCT04243837
2024-04-23
LYT-100 in Patients With BCRL
PureTech
Phase 2
Terminated
50 enrolled
9 charts